CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-30 | Grund Nicholas Chief Commercial Officer | Grant or award · Stock Option (Right to buy) | +320,000 | 320,000 | ||
| 2026-01-30 | Burke Steven Keith SVP, Chief Medical Officer | Grant or award | +204,000 | 1,016,090 | ||
| 2026-01-30 | Burke Steven Keith SVP, Chief Medical Officer | Grant or award · Stock Option (Right to buy) | +320,000 | 320,000 | ||
| 2026-01-30 | Butler John P. CEO and President | Grant or award | +743,000 | 3,463,849 | ||
| 2026-01-30 | Butler John P. CEO and President | Grant or award · Stock Option (Right to buy) | +1,115,000 | 1,115,000 | ||
| 2025-06-30 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Sale 10b5-1 | −41,314 | $3.67 | $152K | 503,586 |
| 2025-06-10 | ZUMWALT LEANNE M Director | Grant or award | +35,700 | 109,400 | ||
| 2025-06-10 | ZUMWALT LEANNE M Director | Grant or award · Stock Option (Right to buy) | +53,600 | 53,600 | ||
| 2025-06-10 | ADAMS ADRIAN Director | Grant or award | +35,700 | 200,500 | ||
| 2025-06-10 | ADAMS ADRIAN Director | Grant or award · Stock Option (Right to buy) | +53,600 | 53,600 | ||
| 2025-06-10 | Wolf Myles Director | Grant or award | +35,700 | 133,381 | ||
| 2025-06-10 | Wolf Myles Director | Grant or award · Stock Option (Right to buy) | +53,600 | 53,600 | ||
| 2025-06-10 | Smith Cynthia Director | Grant or award | +35,700 | 160,933 | ||
| 2025-06-10 | Smith Cynthia Director | Grant or award · Stock Option (Right to buy) | +53,600 | 53,600 | ||
| 2025-06-10 | ROGERS MICHAEL W Director | Grant or award | +35,700 | 161,729 | ||
| 2025-06-10 | ROGERS MICHAEL W Director | Grant or award · Stock Option (Right to buy) | +53,600 | 53,600 | ||
| 2025-06-10 | GILMAN STEVEN C Director | Grant or award | +35,700 | 152,830 | ||
| 2025-06-10 | GILMAN STEVEN C Director | Grant or award · Stock Option (Right to buy) | +53,600 | 53,600 | ||
| 2025-06-10 | FRIESON RON Director | Grant or award | +35,700 | 129,500 | ||
| 2025-06-10 | FRIESON RON Director | Grant or award · Stock Option (Right to buy) | +53,600 | 53,600 |
Page 3 of 21 · 405 trades